2020 Schedule and Program for the ASH Meeting on Lymphoma Biology

The 2020 ASH Meeting on Lymphoma Biology has been canceled. ASH has decided to cancel the meeting as a precautionary measure in response to the COVID-19 outbreak in the U.S. and worldwide. The health and safety of our meeting attendees is ASH’s top priority.

ASH encourages those who had planned to submit abstracts for this meeting to instead submit for consideration to ASH’s Annual Meeting and Exposition, the premier event in malignant and non-malignant hematology. The abstract submission site will open on June 4, 2020.

The following program is preliminary and subject to change.

Thursday - August 6

2:00 p.m. - 7:00 p.m.	Registration
5:00 p.m. – 5:15 p.m.	Welcome, Introduction, and Announcements
5:15 p.m. – 6:00 p.m.	Opening Keynote Address Chair: Ralf Küppers, PhD Riccardo Dalla-Favera, MD The Making of Diffuse Large B-Cell Lymphoma
6:00 p.m. – 7:00 p.m.	Welcome Reception and Exhibits Open

Friday - August 7

7:00 a.m. – 9:15 p.m.	Registration
7:00 a.m. – 8:00 a.m.	Breakfast and Exhibits Open
8:00 a.m. – 10:00 a.m.	Session 1: Germinal Center Biology Chair: Bertrand Nadel, PhD Speakers: Klaus Rajewsky, MD Control of the Competitive Fitness of MYC-driven B Lymphoma Cells Dinis Calado, PhD Differentiation Processes of Germinal Center B Cells and Lymphomagenesis Jagan R. Muppidi, MD, PhD Evasion of Cell Death in Germinal Center-Derived Lymphomas Oral Abstract Talk 1 Oral Abstract Talk 2
10:00 a.m. – 11:15 a.m.	Session 2, Part 1: Novel Genetic and Epigenetic Mechanisms in Lymphomagenesis Chair: Dan A. Landau, MD, PhD Speakers: Ari Melnick, MD Precision Epigenetic Therapy for Follicular and Diffuse Large B cell Lymphoma Hans-Guido Wendel, MD Exploring the Link between Serine Metabolism and Lymphoma Epigenetics Oral Abstract Talk 3
11:15 a.m. – 11:30 a.m.	Break
11:30 a.m. – 12:45 p.m.	Session 2, Part 2: Novel Genetic and Epigenetic Mechanisms in Lymphomagenesis Chair: Dan A. Landau, MD, PhD Speakers: Jude Fitzgibbon, PhD Targeting KMT2D Mutations in Follicular Lymphomas Dan A. Landau, MD, PhD The Epigenetic Evolution of Cancer Cells Oral Abstract Talk 4
12:45 p.m. – 1:45 p.m.	Lunch and Exhibits
1:45 p.m. – 3:45 p.m.	Continuing Conversations
3:45 p.m. – 5:15 p.m.	Poster Presentations
5:15 p.m. – 6:30 p.m.	Session 3, Part 1: Disrupted Signaling Pathways and Microenvironment in Lymphoma Chair: Christian Steidl, MD Speakers: Margot Thome-Miazza, PhD Novel Insights into the Role of the CBM Complex in Lymphoma Karin Tarte, PharmD, PhD Pro-Tumoral Microenvironment in Follicular Lymphoma: Heterogeneity and Function Oral Abstract Talk 5
6:30 p.m. – 8:00 p.m.	Dinner
8:00 p.m. – 9:15 p.m.	Session 3, Part 2: Disrupted Signaling Pathways and Microenvironment in Lymphoma Chair: Christian Steidl, MD Speakers: Margaret A. Shipp, MD Deregulated Signaling Pathways in Large B Cell Lymphomas Martina Seiffert, PhD Myeloid-Derived Suppression and T-cell Exhaustion in the Microenvironment of Chronic Lymphocytic Leukemia Oral Abstract Talk 6

Saturday - August 8

7:00 a.m. - 8:45 p.m.	Registration
7:00 a.m. – 8:00 a.m.	Breakfast and Exhibits Open
8:00 a.m. – 10:20 a.m.	Session 4: Understanding Mechanisms of Sensitivity and Resistance to Novel Therapies in Lymphoma Chair: Ari Melnick, MD Speakers: Ash A. Alizadeh, MD, PhD Disease Monitoring and Outcome Prediction for B cell Lymphomas Using Circulating Tumor DNA Louis Staudt, MD, PhD Overcoming Resistance to Targeted Therapy of Lymphoma using Multi-drug Combinations Anas Younes, MD Biomarker-Driven Trials in the Era of Combination Therapy Oral Abstract Talk 7 Oral Abstract Talk 8 Panel Discussion with Invited Speakers
10:15 a.m. - 10:35 a.m.	Break
10:35 a.m. – 12:35 p.m.	Session 5: NK/T-cell Lymphomas Chair: Wing “John” C. Chan, MD Speakers: Seishi Ogawa, MD, PhD Molecular Genetics of Peripheral T-cell Lymphomas Teresa Palomero, PhD Role and Mechanisms of VAV1 Translocations in PTCL Kojo S. J. Elenitoba-Johnson, MD Novel Insights in the Role of Ubiquitin Ligases in T-cell Function and Neoplasia Oral Abstract Talk 9 Oral Abstract Talk 10
12:35 p.m. - 1:45 p.m.	Lunch and Exhibits
1:45 p.m. – 3:45 p.m.	Session 6: Germinal Center-Derived Lymphomas Chair: Laura Pasqualucci, MD Speakers: Sandrine Roulland, PhD Novel Insights into the Natural History of Follicular Lymphoma Progression Reiner Siebert, PhD New Insights in the Pathogenesis of Burkitt Lymphoma Christian Steidl, MD Pathogenic Crossroads in Primary Mediastinal B cell Lymphomas and Hodgkin Lymphoma Oral Abstract Talk 11 Oral Abstract Talk 12
3:45 p.m. – 5:15 p.m.	Poster Presentations
5:15 p.m. – 6:45 p.m.	Dinner
6:45 p.m. – 8:45 p.m.	Session 7: Chronic Lymphocytic Leukemia and other Small B cell Neoplasms Chair: Elias Campo, MD, PhD Speakers: Davide Rossi, MD, PhD Genomic Complexity in Splenic Marginal Zone Lymphoma Catherine Wu, MD Tumor Dynamics in the Evolution of Chronic Lymphocytic Leukemia Iñaki Martin Subero, PhD Epigenetic Dysregulation in Small B cell Lymphoid Neoplasms Oral Abstract Talk 13 Oral Abstract Talk 14

Sunday - August 9

7:00 a.m. – 1:35 p.m.	Registration
7:00 a.m. – 8:00 a.m.	Breakfast, Exhibits, and Steering Committee Meeting
8:00 a.m. – 9:15 a.m.	Session 8, Part 1: Immunotherapies of Lymphomas Chair: Margaret A. Shipp, MD Speakers: Stephen Ansell, MD, PhD Alternative Checkpoints in Lymphoma Catherine M Bollard, MD Overcoming TGFb in the Tumor Microenvironment with Cell Therapy Oral Abstract Talk 15
9:15 a.m. – 10:50 a.m.	Session 8, Part 2: Immunotherapies of Lymphomas Chair: Margaret A. Shipp, MD Speakers: Ranjana Advani, MD Targeting CD47 for Lymphoma Therapy Ronald Levy, MD In Situ Vaccination for the Therapy of Lymphoma Oral Abstract Talk 16 Panel Discussion with Invited Speakers
10:45 a.m. – 11:05 a.m.	Break
11:05 a.m. – 1:05 p.m.	Session 9: Late-Breaking Scientific Session Invited Speaker 28 Invited Speaker 29 Invited Speaker 30 Oral Abstract Talk 17 Oral Abstract Talk 18
1:05 p.m. – 1:35 p.m.	Closing Remarks
1:35 p.m.	Departures